相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Reprogrammed Cells for Disease Modeling and Regenerative Medicine
Anne B. C. Cherry et al.
ANNUAL REVIEW OF MEDICINE, VOL 64 (2013)
Pilot study using ambroxol as a pharmacological chaperone in type 1 Gaucher disease
Ari Zimran et al.
BLOOD CELLS MOLECULES AND DISEASES (2013)
Ambroxol as a pharmacological chaperone for mutant glucocerebrosidase
Inna Bendikov-Bar et al.
BLOOD CELLS MOLECULES AND DISEASES (2013)
B cell lymphoma and myeloma in murine Gaucher's disease
E. V. Pavlova et al.
JOURNAL OF PATHOLOGY (2013)
Ex Vivo and in Vivo Effects of Isofagomine on Acid β-Glucosidase Variants and Substrate Levels in Gaucher Disease
Ying Sun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Pharmacological chaperones facilitate the post-ER transport of recombinant N370S mutant β-glucocerebrosidase in plant cells: Evidence that N370S is a folding mutant
Gholamreza Babajani et al.
MOLECULAR GENETICS AND METABOLISM (2012)
The promise of induced pluripotent stem cells in research and therapy
Daisy A. Robinton et al.
NATURE (2012)
Induced pluripotent stem cell model recapitulates pathologic hallmarks of Gaucher disease
Leelamma M. Panicker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Gaucher disease gene GBA functions in immune regulation
Jun Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response
Nick Dekker et al.
BLOOD (2011)
Global gene expression profile progression in Gaucher disease mouse models
You-Hai Xu et al.
BMC GENOMICS (2011)
Second-Generation Iminoxylitol-Based Pharmacological Chaperones for the Treatment of Gaucher Disease
Farah Oulaidi et al.
CHEMMEDCHEM (2011)
A clinical perspective of IL-1β as the gatekeeper of inflammation
Charles A. Dinarello
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Gaucher disease with foamy transformed macrophages and erythrophagocytic activity
Maciej Machaczka et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2011)
Blocking interleukin-1 beta in acute and chronic autoinflammatory diseases
C. A. Dinarello
JOURNAL OF INTERNAL MEDICINE (2011)
Aggregation of α-synuclein in brain samples from subjects with glucocerebrosidase mutations
Jae Hyuk Choi et al.
MOLECULAR GENETICS AND METABOLISM (2011)
Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors
Hiroshi Ban et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The pharmacological chaperone isofagomine increases the activity of the Gaucher disease L444P mutant form of β-glucosidase
Richie Khanna et al.
FEBS JOURNAL (2010)
Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage
Pramod K. Mistry et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients
Tamar H. Taddei et al.
AMERICAN JOURNAL OF HEMATOLOGY (2009)
Gaucher disease and monoclonal gammopathy: A report of 17 cases and impact of therapy
Bernard Grosbois et al.
BLOOD CELLS MOLECULES AND DISEASES (2009)
Identification and Characterization of Ambroxol as an Enzyme Enhancement Agent for Gaucher Disease
Gustavo H. B. Maegawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Induced Pluripotent Stem Cell Generation Using a Single Lentiviral Stem Cell Cassette
Cesar A. Sommer et al.
STEM CELLS (2009)
Immunoglobulin and free light chain abnormalities in Gaucher disease type I: data from an adult cohort of 63 patients and review of the literature
M. de Fost et al.
ANNALS OF HEMATOLOGY (2008)
Isofagomine increases lysosomal delivery of exogenous glucocerebrosidase
Jin-Song Shen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Disease-specific induced pluripotent stem cells
In-Hyun Park et al.
CELL (2008)
Identification of Pharmacological Chaperones for Gaucher Disease and Characterization of Their Effects on β-Glucocerebrosidase by Hydrogen/Deuterium Exchange Mass Spectrometry
Michael B. Tropak et al.
CHEMBIOCHEM (2008)
Induced pluripotent stem cell lines derived from human somatic cells
Junying Yu et al.
SCIENCE (2007)
Induction of pluripotent stem cells from adult human fibroblasts by defined factors
Kazutoshi Takahashi et al.
CELL (2007)
Pharmacologic chaperoning as a strategy to treat Gaucher disease
Zhanqian Yu et al.
FEBS JOURNAL (2007)
The iminosugar isofagomine increases the activity of N370S mutant acid β-glucosidase in Gaucher fibroblasts by several mechanisms
Richard A. Steet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Superior effects of high-dose enzyme replacement therapy in type 1 Gaucher disease on bone marrow involvement and chitotriosidase levels:: a 2-center retrospective analysis
Maaike de Fost et al.
BLOOD (2006)
Characterization of human phagocyte-derived chitotriosidase, a component of innate immunity
M van Eijk et al.
INTERNATIONAL IMMUNOLOGY (2005)
ER retention and degradation as the molecular basis underlying Gaucher disease heterogeneity
I Ron et al.
HUMAN MOLECULAR GENETICS (2005)
Gaucher disease: pathological mechanisms and modern management
M Jmoudiak et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Gaucher disease: complexity in a simple disorder
E Sidransky
MOLECULAR GENETICS AND METABOLISM (2004)
Effect of enzyme replacement therapy on gammopathies in Gaucher disease
A Brautbar et al.
BLOOD CELLS MOLECULES AND DISEASES (2004)
Transient expression of wild-type and mutant glucocerebrosidases in hybrid vaccinia expression system
K Hodanová et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2003)
Targeting glycosylation as a therapeutic approach
RA Dwek et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
分享论文
